Thanks for pledging! - Share this with your friends
Thank you for your pledge! We'll be in touch once the campaign meets its goal, and again when it closes, so you know we'll be charging your card.
CDA Health Pty Ltd
I want to embed this investment somewhere
547 people pledged
AU$500,000 minimum target
Pledges will only be confirmed if the target is reached by: 14/06/2019 at 11:00 PM (AEST)Make a Pledge
CDA Health Pty Ltd
CDA Health Pty Ltd is offering fully paid ordinary shares at $1 per share to raise a maximum of $2,000,000
This Offer is made under the CSF regime in Part 6D.3A of the Corporations Act 2001 (Corporations Act). The general public in Australia can buy up to $10,000 worth of shares in this company, as part of the new equity crowdfunding legislation (Note: there is no cap on how much Sophisticated Investors can invest). Please make sure to read the risk warning statement, offer document, and understand the Cooling-Off rights. Instructions on how to register to invest and pledge are here.
The key terms and conditions of the crowd-sourced funding Offer are set out in the Table below.
- When you buy shares in CDA Health you are making an investment into all four of our subsidaries within the rapidly growing Medical Cannabis and Hemp industries.
- The shares you purchase result in owning a percentage of the company and if CDA Health increases in value, your shares do too.
In the future there is the potential for us to go through an initial public offering on a relevant stock exchange, a merger or sale to another company, or a share buyback from the company which are the usual exit events which could allow you to realise your investment.
A LETTER FROM DR BEN, OUR FOUNDER & CHAIR
Thank you for your interest in investing in our company, CDA Health Pty Ltd. We’re proud to invite you to be part of Australia’s first ever Equity Crowdfunded Medical Cannabis investment opportunity.
Prior to Australia prohibiting Cannabis under federal law in 1926, Cannabis was widely used as a medicine dating back 5,000 years. Once again Cannabis has been made available to the general public, with its legal status for medical prescription being reinstated by the Australian Federal Government in 2016.
My personal involvement in medical cannabis began when I learned that the United States Department of Health patented Cannabis compounds as “antioxidants and neuroprotectants’’ in 1998. Prior to discovering this information, my mother had passed away from a rare degenerative brain condition. The rapid onset of this disease was traumatic for our family. And although the disease was neurological, we witnessed more lucid moments from her than I care to remember. My sister Jess will never forget having to take away mums car keys and install an internal door lock to stop her from wandering into the streets. The brain degeneration significantly affected her quality of life and after only 3 years from diagnosis she required 24hr care and assistance. I believe her pain and suffering would have reduced and her life potentially prolonged had we known the US patent existed and had legal access to the neuroprotective properties of Cannabis.
After entering a period of research I discovered many convincing case reports containing phenomenal stories from patients who had survived their illnesses through use of the plant. We uncovered one particular case study that involved lab animals suffering from heart attacks. After being injected with Cannabidiol (CBD), these animals showed a 66% reduction in the magnitude of their heart attacks.
Since 2016, following the re-legalisation of Medical Cannabis, we have been striving to ensure no one will ever have to suffer unnecessarily like my mother did. By 2017, we had proudly founded Burleigh Heads Cannabis Pty Ltd (BHC), which was granted one of Australia’s first Medical Cannabis wholesaling Licences.
Recent reports suggest there are more than 200,000 Australians accessing black-market Cannabis for medicinal purposes, yet only a few thousand have accessed it legally to date. However, the growing awareness and education of both patients and doctors has resulted in legal access rapidly increasing.
Cannabis Doctors Australia Pty Ltd (CDA) was founded by us, a family of doctors and professionals, to streamline the complex process of accessing Medical Cannabis. We’re dedicated to training doctors on the efficacy of Medical Cannabis and how to prescribe the medicine safely and efficiently. Since October 2018, we’ve provided over 1,500 prescriptions to more than 700 patients, which equates to almost a third of the SAS B approvals granted since our launch.
Our first CDA clinic opened in Miami on the Gold Coast, before expanding to further affiliate clinics on the coast, then Melbourne, and Brisbane. The number of our clinics is growing as more doctors approach us about our services. Additionally, to make Medical Cannabis available to all Australians, our doctors provide TeleHealth consultations to every state and territory within the country.
Despite only having opened our doors to patients 6 months ago our waiting lists continue to grow with our flagship clinic in the Gold Coast now out to 9 weeks. The CDA group broke even in February 2019 and continues to make profit gains; few other Australian Medical Cannabis companies have been able to achieve this.
By integrating both the service and product-supply aspect within our business model, we are able to stay aligned with our core values of providing safe, reliable and affordable access to Medical Cannabis now and into the future.
As a family-owned company independent of Big Pharma, with a team of medical professionals, we have set ourselves apart from the multinationals invested in the Cannabis market. We intend to continue our strong focus on patient health, while simultaneously implementing a staged growth plan for the business.
During our time in the Australian Medical Cannabis industry, we have gained a deep understanding of the market landscape. CDA is helmed by doctors who have seen first-hand the positive results of Medical Cannabis for many patients.
Your interest in investing in our company comes at a time of rapid expansion in the Australian Cannabis industry, which is estimated to grow to $3 billion by 2028.
With an eye to the future, we will continue to anticipate regulatory and industry changes, while positioning ourselves as Australasia’s go-to Medical Cannabis provider. We are extremely excited for the future of CDA and welcome you to join us on this journey of pioneering a shift towards safer plant-based medicines.
Kind regards and we hope to welcome you to the CDA family,
Dr Ben Jansen
FRACGP FRNZCGP FRNZCUCP
BHB MBChB PGDipSM PGDipCEM
OVERVIEW OF THE COMPANY AND ITS SUBSIDIARIES
We aim to become the leading patient-focused Medical Cannabis Organisation in Australasia.
CDA Health Pty Ltd (the Company) is the parent company of the Group. The Company, through its subsidiaries, Burleigh Heads Cannabis Pty Ltd (BHC), Cannabis Doctors Australia Pty Ltd (CDA) and Cannabis Doctors Aotearoa Limited (CDANZ), offers a clinical service alongside a product supply chain.
BHC is a fully licensed wholesaler and offers a market entry solution to local and international manufacturers and cultivators seeking to gain access to the Medical Cannabis industries in Australia and New Zealand.
Our clinical arm CDA provides efficient, affordable and easy service for patients requiring Medical Cannabis access approvals. CDA operates doctor-led Medical Cannabis clinics along with an Australia-wide TeleHealth consultation service whereby patients can consult from the comfort of their own home.
CDA is one of the first (possibly the only) Medical Cannabis groups to pass the key milestone of 1000 patient approvals and 1500 prescriptions, since launching in October 2018.
The clinical model is run by CDA’s internal doctors and external affiliate doctors who have been chosen to undergo the CDA training program. The training involves the education of all regulatory and compliance considerations, familiarisation with the consultation and application processes and a series of templates that our in-house doctors have developed.
Patients are engaged via our CDA Clinical brand. Once a patient has registered on our website a CDA customer service representative will personally call the patient for a free eligibility screening and to answer any questions that the patient might have. This builds trust into the CDA brand and allows a high level of care in the initial engagement phase before patients are referred out to one of the affiliate clinics.
Cannabis Doctors Aotearoa Limited (CDANZ) was established to leverage New Zealand’s less stringent legislation, whereby doctors can prescribe Medical Cannabis to patients without the need for complex approvals. CDANZ utilises the same patient-focused clinical model as CDA Clinics to enable international growth of the CDA Brand.
CDANZ will provide operational and technical knowledge as well as intellectual property to pharmacies and affiliate doctors within our network that are currently seeking access to Medical Cannabis. Operational planning is already underway and we aim to provide NZ patients with the same, trusted service and products by June 2019.
The final subsidiary, Healthy Not High Pty Ltd (HNH), completes the product offering. HNH is a hemp food and nutraceuticals brand that aims to have sustainable Australian-grown hemp products sold online and in-store by mid-2019. The subsidiaries are all wholly owned by the Company, apart from BHC which is 90.9% owned by the Company.
Burleigh Heads Cannabis (BHC) is a fully licensed Medical Cannabis wholesaler. BHC utilises its secure temperature-regulated storage facility on the Gold Coast and national pharmacy partner network to provide local and international producers with streamlined importation and distribution services throughout Australia. BHC has seen strong growth in sales revenues since the period commencing October 2018.
Healthy Not High Pty Ltd (HNH) is a hemp food and nutraceuticals company based on the Gold Coast. The brand expands the group’s umbrella to leverage the rapidly growing hemp market in Australia. HNH’s aim is for consumers to be able to access quality products from Australian-grown hemp via retail outlets and online sales. Both manufacturing (contract) and distribution is in place and products are due for release into the market by mid-2019.
The Company is embarking on an equity raise offer through crowdfunding, with a goal to remain a strong, adaptive and independently owned mainstay of the Australian Medical Cannabis industry.
This is an investment opportunity for you to own a piece of a progressive patient-focused Medical Cannabis Company that aims to change the paradigm of healthcare in Australasia.
OUR WHY & OUR PURPOSE ARE CENTRAL TO OUR BRAND
We believe everyone has a right to access safe and affordable plant-based medicines.
To put it simply, each of the founding shareholders and directors emphatically believes in the therapeutic and medicinal properties of Medical Cannabis. We consider it our mission to make affordable, high-quality products available to patients who need Medical Cannabis.
WHY ARE WE EQUITY CROWDFUNDING?
We want to deliver our company objectives without compromising our principles in the pursuit of short-term profit.
Through Equity Crowdfunding we’re offering patients, doctors, advocates and retail investors the opportunity to share in the Company’s journey into the future.
We want to give everyday Australians and sophisticated investors an opportunity to be part of our business. By offering Equity to like-minded people in our community, we look to remain independent from Big Pharma.
We’re thrilled to be offering you a chance to join our company. You can help us continue to provide compassionate care for people in need by owning a piece of the rapidly growing Medical Cannabis market.
KEY MILESTONES TO DATE OF CDA AND ITS SUBSIDIARIES
HOW DO OUR COMPANIES WORK TOGETHER?
CDA receives a number of revenue streams via our storefront clinics and Australia-wide TeleHealth services, which include initial consultations, follow-up consultations, and 6-monthly renewal consultation fees. Moving forward, CDA aims to expand its consultation services through franchising the CDA Clinics brand and increasing its affiliate medical practitioner numbers for both In-Clinic and TeleHealth consultations.
2. PRODUCT WHOLESALING
BHC is able to import, store and supply Australian doctors and pharmacies with a diverse range of Medical Cannabis product types and brands. BHC is able to leverage its supplier status to provide CDA patients with a reliable resource of affordable quality products.
This unique set-up of the two subsidiaries allows us to subsidise product costs, which can be passed directly onto patients. It is our fostering of strong patient relationships that has formed a robust distribution avenue. This in turn has resulted in powerful buying opportunities with international partners. Diversifying puts us in a position to safeguard against industry reliability issues and price control, while scaling up both businesses on an integrated sliding growth scale.
OUR THREE-PHASE GROWTH STRATEGY
Our strategy is broken into three distinct phases. By progressing through these stages we’re able to operate more economically, while providing exceptional service to our patients.
OUR MANAGEMENT TEAM
Each and every member of the team at CDA Health believes in the healing power of Medical Cannabis. Each one of us is passionate about the industry and offer diverse skills and experience in our relative areas of expertise.
From left to right: Dr Ben Jansen, Guy Headley, Jessimine Jansen, Dr Matua Jansen
Dr Ben Jansen - Chairman & Clinical Director, FRACGP, FRNZCUCP, FRNZCGP, BHB, MBChB
Ben is a co-founder of Cannabis Doctors Australia and lecturer on Medicinal Cannabis. He is responsible for regulatory compliance and clinical operations within the Company.
Since 2005, Ben has worked as a Doctor of Medicine with three Medical College Fellowships. His primary background is in General Practice. As a result of Ben’s research, he is confident of bringing novel, innovative and profitable Medical Cannabis products to market in Australia and beyond.
Ben has been instrumental in designing the CanView™ platform, which once completed will increase efficiencies in the patient integration and monitoring process. This is expected to help unlock further opportunities for CDA growth.
Dr Matua Jansen - Managing Director, C.Hsc, BHB, MBCHB (Dist.), MBA
Matua is responsible for the Business Strategy, Risk Management and TeleHealth Operations.
Matua is a Doctor of Medicine with a Masters in Business Administration. Matua has spent almost a decade working in oncology for the largest private hospital provider in Australia, where as both a clinician and manager, he has seen the issues associated with opioid addiction. With his extensive network of business contacts, he is focused on developing key partnerships and customer relationships.
Guy Headley - Director of Operations
Guy is co-founder of Burleigh Heads Cannabis and Director of Operations.
Having been active in the Australian Medical Cannabis industry since 2016, Guy brings a wealth of knowledge to his role as CDA Director of Operations. Additionally, Guy has more than a decade of experience in the procurement negotiation.
Guy has utilised his professional standing to help build and maintain strong relationships in the global cannabis supply chain and domestic regulatory agencies to ensure Burleigh Heads Cannabis maintains a robust market presence.
Jessimine Jansen - Marketing Director, BAPsych, BAMedia&Comms, PGDipFilmProd
With over a decade of experience driving complex projects within large organisations such as Ernst & Young (EY), Sky TV and the Commonwealth Games 2018, Jessimine brings a diverse mix of business disciplines and perspectives.
Since committing to CDA in October 2018, Jessimine saw a need to connect busy doctors to the patient experience and was the driving force for the creation of CDA Clinics. Jessimine was also the mastermind behind the CanView™ platform.
With a passion for system efficiency and an analytical approach, Jessimine keeps a keen eye on expenditure and risk management. She achieves all of this while ensuring the business remains in touch with our most important aspect, our customers.
Stone Group Lawyers
Head Legal Counsel
Principal Nick Stone and Senior Associate Dan Birch, supported by a team of legal experts at Stone Group Lawyers, have a combined 20+ years’ experience across commercial, corporate and litigation practice areas. Both Nick and Dan have an active advisory involvement with the Company. They have proven experience guiding professional clients through commercial transactions to help them reach their full business potential.
Dr Cris Filipe-Alves, PHD, MSC, BSC, PGDIPSCICOM
Cris is currently the Director of Quality Assurance for Craft Cannabis BC. He has been active in the Canadian cannabis industry in roles of multimodal cannabis extraction, novel product formulation, research and development, laboratory design, guideline production, and scientific quality inspection. Cris brings his vast experience to CDA’s exclusive product manufacturing and beyond into GMP extraction.
Krish Rambishiwar, BPharm, RegPharm NZ, MPS
Krish is currently running a successful Pharmacy wholesale enterprise in New Zealand and has a comprehensive knowledge of contemporary New Zealand cannabis legislation. Krish has a passion for developing new pharmaceutical products and plays a key role in our New Zealand Expansion.
THE COMPETITIVE LANDSCAPE
CDA’s competitive advantage starts with our two sided, integrated business model which positions us uniquely in the market.
- We’ve removed ‘middlemen’ throughout the prescription-to-patient process. This not only increases patient affordability but fewer hands throughout this process could help maintain higher standards of quality and reliability
- We’re a doctor-led company, independent from big pharmaceutical companies and large international enterprises, which enables more flexibility within the market. Our ability to remain dynamic allows us to rapidly integrate the latest developments within the industry and focus on patient outcomes
- We are fully licensed to wholesale and are legally able to store all products in-house. We hope to move into manufacturing and cultivation, which, if we are able to do, will shift us from a prescription-to-patient process to a plant-to-patient process.
- Strong intellectual property and operating experience from both the doctor and product aspect
- Our focus on streamlined, personalised patient care allows our patients to remain informed and have more control over their medical journey, while fostering long-term relationships with our brand
Listed competitor comparison
The table below is a comparison with a suitable competitor that is listed on the Australian Stock Exchange. Please note the differences in line item dates that reflect the most current statistics publicly available.
- Column 1 shows the Competitors standing as at their IPO in September 2018,
- Column 2 shows their progress after capital raise and market growth for the first quarter of 2019.
- Column 3 data is current as at 31 March 2019 and shows CDA Health information for the same first quarter of 2019
Listed competitor comparison 1. Company Valuations
Listed competitor comparison 2. Company Financials
* Based on last quarter sales reported less expenses paid detailed in the company cashflow statement. Actual loss for the quarter may vary due to movements in accounting accruals.
Listed competitor comparison 3. Company Overviews
* all trademarks relevant to the Company and Group are held by the Company and available for use by the Subsidiaries by way of licence agreement. Where BHC acts as a distributor for imported products, BHC will obtain licences for the use of the relevant intellectual property.
** Quarterly update dated 4 April 2019, states that competitor accrued more than 100 patients in a month for the first time. It can be reasonably inferred that at the date of publication of their Offer document on 4 September 2018, there were under 100 patients per month.
CDA Health is uniquely positioned in the Australian Medical Cannabis industry, already generating enough revenue to operate without external funding. This was shown by breaking even in February 2019, producing a total Net Profit of $36,967 in March 2019 and $78,396 in April 2019.
We are proud of what we’ve achieved with limited resources. However, we require funding to scale and meet our exponentially growing demand for goods and services. With the investment funds raised from this round we commit to continue operating in a lean, strategic manner.
Burleigh Heads Cannabis Pty Ltd began trading in January 2018, Cannabis Doctors Australia Pty Ltd (CDA Clinics) began trading in October 2018 and the group was consolidated into CDA Health Pty Ltd in early March 2019 which currently operates solely as a holding company.
Cannabis Doctors Aotearoa Limited and Healthy Not High Pty Ltd have secured key partnerships and are ready to commence trading, however, these entities have not yet generated any income and have incurred only nominal amortization expenses.
Below is a summary of the financial statements for the current financial year dated 1 July 2018 to 30 April 2019. A copy of the financial statements prepared by CDA’s accountants, MWM prepared in accordance with the Australian Accounting standards, is available in appendix 2 of the offer document.
An investment in the Company should be seen as high-risk and speculative. A description of the main risks that may impact our business is included in our offer document. Investors should read this section carefully before deciding to apply for shares under the Offer. There are also other, more general risks associated with the Company (e.g. risks relating to general economic conditions or the inability to sell our shares).
TERMS OF THE OFFER
CDA Health is offering up to 2,000,000 fully paid ordinary shares at an issue price of $1.00 per share to raise up to $2,000,000.
- Cooling-off Rights - You have the right to withdraw your pledge for any reason (including if you change your mind about investing in the Company). You must do so within five business days of making your application (the Cooling-off Period) by emailing [email protected] with your full legal name and number of shares you pledged for.
- Communication Facility for the Offer - You can ask questions about the Offer on the Question tab above.
- Effect of the Corporate Governance Concessions - There are some concessions around the Annual Report, Takeovers and Related Party Transactions.
USE OF FUNDS
Over the past two years the team at CDA has gained an in-depth understanding of what is required to succeed in Australasia’s Medical Cannabis market.
Receiving maximum investment and implementation of our 2019 strategy will underpin CDA Health’s status of being a strong leader in the Medical Cannabis industry throughout the Australia-Pacific region. CDA will thereby be in a position to capitalise on our first mover advantage and garnish attractive opportunities, such as mergers, acquisitions or listing on a relevant stock exchange.
The table below sets out the intended use of funds raised under this Offer, based on the minimum and maximum subscription amounts.
Manufacturing Capabilities ($0 min - $300,000 max)
- Applications at state and federal levels for a manufacturing licence will commence immediately, to coincide with an application to the TGA for a Good Manufacture Practice (GMP) certification upon successful fundraising.
- If our maximum goal is met, we aim for construction of facilities to begin before the end of 2019.
- If we do not meet our maximum funds raised, we intend to implement construction at a later date using company revenues.
Sales and marketing ($50,000 min - $155,000 max)
- Affiliate Doctor Education and Onboarding - The team at CDA intends to increase the number of educated prescribing doctors in Australia and will dedicate resources to help reach this goal. Sales and marketing costs include the expansion and implementation of our affiliate clinics and doctor program.
- New Zealand Expansion - If our maximum is reached, we intend to allocate resources into onboarding and educating our existing doctor network. This will position CDA as a first mover in the local Medical Cannabis industry and help accelerate our entry into the New Zealand market.
Information Technology (IT) investment ($50,000 min - $170,000 max)
- Minimum goal - automate internal processes in order to improve time resources, scalability and client relationship management.
- Maximum goal - development and implementation of our CanView™ platform.
Working Capital ($367,000 min - $1,200,000 max)
- Purchase further wholesale orders.
- Overhead costs, such as rent and admin expenses, as maximum raise will allow additional physical clinics to open.
Employment of key staff. We will commence recruitment for the following positions:
Business Development Manager
Patient Care Managers
- Provide working capital to carry out the Group’s business objectives as determined by the Directors.
Director and senior manager remuneration. Our management team so far has been working on reduced compensation.Therefore, based on the amount of money raised, we aim to increase salary to be more aligned with market rates. This can be found under 3.2 Use of funds in the offer document.
Offer costs ($33,000 min - $123,000 max)
The costs of the Offer include the Intermediary’s fees under the hosting agreement between the Company and the Intermediary. These fees are 6% including GST on the total amount raised plus an application and onboarding fee of $3,000 including GST.
Other than as specified above, no other payments from the funds raised will be paid (directly or indirectly) to related parties, controlling shareholders, or any other persons involved in promoting or marketing the Offer.
Long-term Additional Funding Requirements
We expect that the Maximum Subscription amount will be sufficient to meet the Company’s Phase 2 objectives.
If only the Minimum Subscription amount is raised, the Company may require further funding to be able to carry out our intended activities over the next 12-18 months.
In such circumstances, the Company may consider undertaking a further crowd-sourced funding (CSF) offer under the crowd-sourced funding regime. Until additional funding is obtained, we may need to scale back sales and marketing and production activities and continue to focus our cash resources on improving cash flow through our core business activities, which encompass both clinics and wholesale.
NOTE FROM PLEDGEME
- PledgeMe have completed background checks on the Company (CDA Health Pty Ltd) and its Directors (Ben Jansen, Matua Jansen, Guy Headley and Jessimine Jansen). We found no adverse findings in our checks. Please read the warning statement, offer document and ask questions before investing.
- PledgeMe will receive 6% (GST inclusive) of the funds raised if the goal is met by the deadline.
Update from PledgeMe & CDA
24/06/2019 at 5:42 PM
Your Investment - Update from PledgeMe
PledgeMe are working through verifying all of your identities and processing your pledges for our campaign. If you haven't heard from them, check your junk mail or the notifications tab on your PledgeMe profile, or send them an email on [email protected].
Update from CDA
Since the close of our equity crowdfunding campaign, we have been hard at work and have some exciting updates to share with our investors!
Cannabis Doctors Australia and CDA Health have been nominated for 3 awards at the upcoming Australian Cannabis Industry Awards.
Winning these awards could mean more credibility for our brands and this would build more value into our company. If you would like to support us please vote for CDA using the links above.
Update from the Australian Hemp and Cannabis expo
Dr. Ben spoke at the Australian Hemp and Cannabis expo last weekend in Adelaide. Sharing case studies from patients and spreading the word on how CDA can facilitate access for those seeking treatment.
This exposure is in line with our strategy of reaching outside of Queensland and New South Wales as we grow.
CDA has secured a new distribution agreement with listed cannabis healthcare company Bod Australia (ASX: BDA).
Under the agreement, Bod will gain access to BHC's wholesale network and will be able to utilise CDA's education, support and products for its network of patients and doctors seeking access to medicinal cannabis in Australia. Specifically, the agreement will see Bod's MediCabilis product distributed and promoted around Australia.
For CDA this means an ability to facilitate access to a larger range of products while improving the reliability of supply for patients.
Read more about it here:
Our team is already growing
Since closing, we have hired two new team members into our patient care team who will assist with streamlining our patient on-boarding and information dissemination. We will be hiring some more recruits in the coming weeks and months which will help us to scale up quickly!
Thanks again for your investment and support.
8 HOURS AND COUNTING --- how close can we get to the maximum!?
14/06/2019 at 3:39 PM
Hello to all existing and new pledgers (and followers)!
This week has been huge so far. Over 200 people pledged nearly $1,000,000. Taking the total amount invested right now to $1,311,000 and 262% funded from our original goal.
While there's been a huge amount of work put in from the whole of the CDA Team, this wouldn't have been possible if it wasn’t for every one of our pledgers and supporters getting the word out.
Thank you all.
As for what the homestretch looks like...
A few updates ago we mentioned the normal trajectory of what a crowdfunding campaign looks like, with the majority of pledges coming in at the start based on excitement, and the end based on the deadline. Well, the charts below represent that idea very well, and if you've been jumping back into the page every so often to get an update, you will have seen first hand our one was no different.
LAST MINUTE PLEDGER QUESTION: Is it possible to pledge again?
In the countdown to the final hours we've had a few messages from people who have already pledged but want to know if they are able to top up their original amount in order to help get it as close to the max amount as possible before the campaign closes.
The answer is YES, anyone can pledge as many times as they wish up to the maximum amount of $10,000 (unless you are a sophisticated investor where there is no limit)
All you need to do is follow the same process you previously did to make your initial pledge.
We thank you once again
It is exciting times for all involved and with one last HUGE push, we hope that everyone sees this campaign as a success.
As always, we're happy to answer any questions about the investment and will be working right up to the very last minute of the campaign to see it through.
From everyone of us here at CDA Health, thank you.
We look forward to seeing you on the other side!
1 DAY LEFT TO INVEST --- nearly $200,000 pledged in 2 days!
13/06/2019 at 1:46 PM
Hello to all existing and new pledgers (and followers)!
A very quick update for everyone today…
The last couple of days have seen close to $200,000 raised from over 150 people which we're extremely grateful for.
Now with less than 48 hours remaining in our first and only share offer to the general public, we're doing everything we can to reach as close to the max funding goal as possible.
While we have expressed exactly what we'll be doing with the funds and what the potential for the next stage of growth is, we wanted to be explicitly clear on the underlying reasons for our strategy.
To put it simply… for the benefits of the patients, shareholders and doctors. We know that if these groups of people are served to the highest level, then we as the company will benefit too.
Here are the benefits for each of our core groups broken down
Benefits to patients:
We're a patient focused company and everything we aim to do with the funds raised will benefit you.
- Make products more affordable
- Increase reliability so that the products needed are always available
- Make access to educated and trained doctors easy and for your health and wellbeing to be put in a positive light
- With more access and quality products we aim to see a drop in opioid use
Benefits to Shareholders:
This is likely to be the only time that we offer company shares to the public. We’re thrilled to have so many people who are now part of the journey.
- First external shareholders before a period of potentially rapid growth
- Realise investment value upon our next major liquidity event
- Own one of Australia's top private Medical Cannabis Companies not exposed to the same volatility seen on the public market
- Have a voice in the future of the industry in Australia
- Be part of a powerful, likeminded community that together has the impact to make change
Benefits to doctors:
Doctors are an extremely important part of the equation in the Australian industry landscape and it is one of our primary focuses to educate and onboard as many as possible around the country.
- Ability to become a part of the trusted CDA brand and provide a new service to patients wanting to access Medical Cannabis
- Be ahead of the curve and become the known specialist in your area
- Take advantage of the industries infancy to educate others and open opportunities for alternative
As we begin to close out this investment offer we hope you've had a good look through the offer document and have seriously considered investing in the future growth of Medical Cannabis in Australasia.
We thank you once again for your support and look forward to growing CDA Health together.
—CDA INVESTMENT OFFER CLOSES 11PM TOMORROW—
To invest visit: https://www.pledgeme.com.au/investmen…/17-cda-health-pty-ltd
WE'RE NOW OVER 100% FUNDED! THANK YOU!
12/06/2019 at 1:54 PM
Hello to all existing and new pledgers (and followers)!
A huge thank you to each of the 270+ people who helped reach our minimum funding goal last night!
This means that all current pledgers, and those who do so from now are guaranteed to be issued shares of CDA Health.
This is a huge vote of confidence and now shifts the focus to see how close we can come to the $2m maximum amount.
Every dollar towards this amount means that we’ll closer in be able to implement all of Phase 2 in our plan with the goal of increasing the value of the company overall in a shorter amount of time.
Below we have listed out those key points of Phase 2 and what they will enable us to do, BUT FIRST, and more importantly, we wanted to share a story that Dr Matua shared on our FB live event last night. This is one of the core reasons we do what we do and why we are so passionate about putting the patient first…
WITH THIS INVESTMENT WE AIM TO STOP THESE STORIES FROM HAPPENING
We have emphasised our values of being patient-focused, transparent and continuing to put a face to the Medical Cannabis Industry in Australia, but what does that mean in reality?
We recently heard from a middle aged female patient in rural Victoria who has chronic pain and wanted more than anything to stop taking opioids that were doing more harm than good. She went to see her GP for a referral in order to consult with one of our CDA doctors.
While the first GP gave her a firm no, it was her second try that became alarming after we received his call with a very distressed patient crying in the background. His uniformed view that there is no evidence of Medical Cannabis benefiting chronic pain symptoms turned to threats. Threats of going against his Duty of Care as a Medical Professional to assist a patient with legal medicines or alternative if they cannot do so themselves. (both ethically or if they are uneducated in how to)
Obviously, this goes against our core values of putting control back in the hands of patients, and for them to have a say in their health care and wellbeing. This situation was far from acceptable by our standards.
Within 1 week of the call, the CDA team had found another doctor to give her the referral, consulted with her in order to discuss her expectations and set clear treatment goals, and sent the script to the pharmacy for the Medical Cannabis product that suited to her.
One of our main goals for this next phase is to train and educate as many doctors around the country as possible, so these types of situations don’t happen.
With this current investment we aim to fast track this as a priority.
With full investment we aim to implement all of our Phase 2 strategy:
Phase 2 is all about providing patients with easier and more streamlined access to affordable Medical Cannabis products through both CDA Clinics and Burleigh Heads Cannabis.
We aim to:
1. Ramp up our CDA Affiliate Doctor program = enables more patients to consult with trained doctors to access products
2. Obtain our Manufacturing License and develop in-house capabilities = enables us to turn raw bulk product into finished goods more reliably and at a lower price to patients
3. Develop our Canview platform = enables a more streamlined, interactive journey for both patients and doctors
We believe this will put us in a strong position within the market and allow us to sustainably work toward our 10,000 patient goal and continue to develop the steps of our true plant to patient model. The first of its kind in Australia.
With $100,000 pledged yesterday and the investment secured for everyone who has pledged so far, we now want to push towards the importance of getting further to the $2m maximum.
There are now only 2 days for everyone to spread the word one last time in order to reach the largest audience possible and give the company the best chance to deliver on every shareholders goal.
Thank you again to everyone who has supported and helped to spread the word so far, we look forward to embarking on this next part of the CDA Health journey together!
If you know someone who you think would be interested in investing, you can send them this link: https://www.pledgeme.com.au/investments/17-cda-health-pty-ltd
—CDA INVESTMENT OFFER CLOSES 11PM THIS FRIDAY—
3 days to go, 90% funded, 233 investors
11/06/2019 at 12:55 PM
Hello to both our existing and new pledgers (and followers)!
It's been a big month, with it, as expected coming right down to the very last days where we’re looking to everyone who has followed along closely, to get in and buy their shares before it’s too late.
We have to stress that this will be the only time that we'll be offering up shares of CDA Health to the public, so we encourage all that haven’t pledged yet to do so today.
To make the biggest impact possible and grow the business to the extent we know is possible, we need to raise as close to the full $2m as we can. The more we can raise the better your investment will become…
Here is how to avoid the 2 equity crowdfunding deadline mistakes:
1. One of the most common mistakes that people make is waiting until the very last minute in order to see what the total is before making a pledge. This usually means hundreds of people try to invest last minute on the platform. Inevitably there will be some of you who will experience technical issues and with time firmly set at 11pm on Friday you may not have enough time to get any further documentation etc needed, causing you to miss out.
2. The other mistake is to see how a campaign goes and what the company achieves over the next while before looking to invest at a later date. While this might be the case in other campaigns, this will more likely than not be the only time we offer shares to the public before a major liquidity event, obviously with the goal of a much higher valuation.
We're a revenue generating private company, poised for exponential growth in a rapidly growing industry. The value lies in early stage investments; in getting in 'at the grass roots.
To put it simply… TODAY IS THE DAY.
Today is the ‘safe day’ for anyone you know who has been thinking about investing, to do so before they miss out. Maybe, they might even receive a call from you to hurry them along to do it…
7pm tonight on Facebook Live: Dr Matua Jansen & Lucy Haslam ‘Part 2’
If you know, OR want to know anything about the Medical Cannabis industry in Australia, you will want to make sure you join us on Facebook tonight.
We are very grateful that Lucy Haslam from United in Compassion has agreed to open up once again about her story, her beliefs and her passion to bring easier access to patients wanting Medical Cannabis products. She will be going over what both businesses and the general public can do to help.
What are you investing in?
When you invest in CDA Health you're investing in the future growth of all of our companies that have been set up to cater to each of the main segments of the market in Australia and New Zealand.
- CDA Clinics: Doctor-led, patient focused Medical Cannabis clinics with TeleHealth and affiliate doctor consultation services.
- Burleigh Heads Cannabis: Fully licensed Cannabis importer & wholesaler (QLD)
- Healthy Not High: Hemp & Nutraceutical retail products using Australian grown Hemp.
- CDA NZ: Our proven clinic model expanded into New Zealand
How to invest before the deadline this Friday
For those of you who have already invested, we thank you very much and all that is left for you to do in order to make this a success is share the campaign link with others you think may be interested.
Here are the exact steps for those who still need to pledge this week:
3. Visit the CDA Health campaign page and Pledge. (You'll be prompted to create an investor profile with 2 valid forms of ID for share issuance):
*For anyone wanting to invest with their SMSF, a Trust or as a Company you'll register and make your pledge as an individual and then, only after the Pledge has been made you'll need to email through the extra requirements detailed in this guide here.
We thank you for all of your support so far
From all of the team at CDA Health, we thank you and will be pushing all the way to the end in order to ensure we get as close to the $2m as possible.
From day one our mission has been to bring easy access and safe, affordable products to patients in need, which is our driving force every day to do whatever it takes to make it happen.
To have so many incredible new supporters and shareholders only emphasises this drive, so, once again… thank you!
To invest visit: https://www.pledgeme.com.au/investmen…/17-cda-health-pty-ltd
9 days to go, 74% funded, 173 investors
06/06/2019 at 10:56 AM
Hello to all of our new pledgers (and followers)!
Today brings us only 8 days away from the end of the CDA Health crowdfund.
For everyone who has pledged to date, we thank you very much.
We're completely self-funded to date and this is the first and possibly only time we'll be offering up shares prior to any major liquidity event taking place.
However, It is at this point that we do need to remind everyone that if we don’t hit the minimum of $500,000 then all pledges will be cancelled and no shares will be issued.
This means that over the next 8 days we all need to do whatever it takes to ensure the campaign is a success, and if you are still wanting to invest, but haven't got round to it yet - now is the time!
If you haven't already downloaded the full offer document, you can click the button below to and read over it in the next few days before the campaign closes.
We're growing and we need to expand…
We've launched this investment campaign at a time where we are experiencing first-hand the struggles of expanding to keep up with demand. However, we have been very careful to not grow too quickly and compromise our core service standards.
At the time of the launch we had a 9 week wait time for patients, a long list of affiliate doctors waiting to be on-boarded and product order volumes increasing nearly every week.
Now a month later, the demand for our services and products has increased even more. Here's a quick update of where we're at:
- 900+ Patients
- 1,300+ SAS B Approvals
- 1,800+ Prescriptions
- 500+ new patient enquiries for the month of May
- CDA Affiliate Doctor Franchise Program underway
- 2 new hires in our Patient Care Team
- 2 International distribution agreements
- $370,000 investment pledged so far
We are well on our way to providing streamlined access and affordable Medical Cannabis products to patients in need but we need to expand quickly and we need your help to do it.
We invite you to PART 2 of our FB Live interview with Lucy Haslam
If you did join us last week we thank you very much and apologise for the internet issues that we experienced, meaning we had to end the broadcast early.
This is an interview that is very important to a lot of people so we've re organised part 2 with Dr Matua and Lucy for next week. We hope to see you there and would love to hear any questions you do have for either Dr Matua or Lucy beforehand by putting them in the discussion section of the event in the link below.
Thank you all for your support so far…
As we begin to close out this investment offer we hope you've had a good look through the offer document and seriously considered investing in the future growth of Medical Cannabis in Australasia.
For your reference we've included the button below that will take you directly through to the PledgeMe page, and also enable you to share it with your networks or audience.
We thank you once again for your support and look forward to growing CDA Health together.
12 days to go, 66% funded, 155 investors
03/06/2019 at 11:10 AM
Hello to all of our new pledgers (and followers)!
We're now on the tail end of our investment campaign, and history tells us this is where things start to get exciting.
Our team has run multiple crowdfunding campaigns over the years and if there's one thing that we know, it's that the last part of a campaign is where everything comes together and all the action happens. This can be seen on the chart below.
In fact, the last campaigns that have run on Pledge Me received between $600,000 to over a $1,000,000 in the final days resulting in superseding the minimum.
We've been getting the word out there every single day and you'll see by the media outlets below, the share offer is most definitely out there.
Now comes the time for everyone around the country who's been following along, researching, speaking with accountants and considering the offer with friends to make their move before it's too late.
We hope that you too have decided to join us, and invest in one of the leading Medical Cannabis companies in Australia right now.
CDA featured in the media around the country
We've been overwhelmed with the positive support from the media in helping us get the word out in a way that aligns with our core values and mission.
Here are just a few of the outlets that have featured us over the last 2 weeks and we hope there'll be a bunch more leading into the end of this investment campaign.
Our way of saying thanks…
As we've mentioned before, the support and new interest from everyone has been incredible.
This isn't just from the investment side but from the 100's of new patients who have enquired about getting Medical Cannabis through our clinics.
As a way of saying thanks, and also to keep awareness growing in new ways while abiding by Australia advertising laws for Medical Cannabis, we've launched a giveaway of 1,000 extra founder shares worth $1,000.
To be in the draw, simply visit our Facebook page by hitting the button below and follow the instructions in the post. We're excited to announce the winner this Wednesday during our Facebook Live Event.
That's it for now. For those who have been following along up unitil now and have not yet pledged, we hope you have some time this week to download the offer document and seriously consider investing in the future of Medical Cannabis in Australasia.
We thank you once again for your support and look forward to growing CDA Health together.
17 days to go, 60% funded, 126 investors
29/05/2019 at 8:48 AM
Hello to all of our new pledgers (and followers),
It's been a huge 12 days so far and we’re extremely thankful for everyone who has pledged to become a part of Cannabis Doctors Australia, and this movement overall. Reading through all the personal stories of why people are so keen to get involved is why we're here in the first place, and is the fuel we're using to ensure this campaign is a huge success.
We're near the halfway point in our investment campaign, and we believe your support is crucial to realise this opportunity of bringing Medical Cannabis to as many patients as possible.
As we've mentioned before, there are still a few hundred people who expressed interest when we first confirmed our decision to go ahead with the share offer, but who haven't yet actioned their investment.
Whether you're an advocate of Medical Cannabis products, the industry as a whole, or are in it to increase potential returns in your portfolio, we encourage you to pledge and or share the campaign (links below) as soon as possible so that the first 500,000 shares are secured for everyone.
As always, we're here to answer any questions by emailing [email protected]
WE INVITE YOU TO TONIGHTS EVENT (Wednesday 29th 7:00pm) : Special Guest Lucy Haslam
We're excited to have Lucy join us for a Facebook Live discussion about Medical Cannabis and the access issues due to the current legislation.
Lucy is a superstar in this space, and as of August 2013, has spearheaded the movement to re-introduce Medical Cannabis into Australia.
Lucy witnessed the dramatic relief her son Dan (suffering stage 4 bowel cancer) gained from using Medicinal Cannabis. Dan also championed the cause, alongside his Mother.
Together they started a social campaign which ultimately changed Australian Laws. Lucy says that she used to feel proud of that achievement but now feels that Australian legislators have produced a system set up to fail patients like Dan.
On Dan’s deathbed she promised to make access to cannabis better for Australians.
This will be an extremely insightful discussion with a chance to also get any questions you have answered by her.
The top investment FAQ’s
We’ve had a lot of the same questions starting to come in about our crowdfund, so we’ve put the main ones here so you can reference back to them if anyone asks.
Before we list out the main questions this is who we are, what we do and why we are unique:
We’re a doctor-led, patient focused Medical Cannabis Company that is changing the paradigm of healthcare in Australasia. We have physical clinics and TeleHealth services to facilitate patient consultations, and also a fully licensed wholesaler that imports and supplies our patients with safe, reliable and affordable Medical Cannabis products.
1. Where do I invest?
Through the PledgeMe platform - https://www.pledgeme.com.au/investments/17-cda-health-pty-ltd
2. How do I invest?
You will need to register as an individual investor on PledgeMe by giving 2 forms of ID. You can then pledge on the CDA Health page. Instructions: https://www.guide.pledgeme.com.au/how-to-invest
3. Can I invest with a SMSF, trust or as a company?
Yes you can. You need to register in your own name first and pledge. You can then email [email protected] where the additional info is collected. Instructions: https://www.guide.pledgeme.com.au/how-do-i-invest-through-my-australian-company-or-smsf
4. What is the min & max I can invest?
You can become a part of CDA Health by purchasing as little as $250 worth, up to a maximum of $10,000 unless you are a sophisticated investor. Every dollar counts!
5. What is a Sophisticated Investor?
This means you’ve earned $250,000+ for each of the previous 2 years OR have $2.5m in assets. Being a Sophisticated investor means you can invest any amount and from any country in the world.
6. What will my return be?
An important question. Under the current law we’re not allowed to provide any financial projections which restricts what we can show about the potential returns. What we can say is that we’ve proven our unique model and are already generating revenue. If we're able to secure these funds and implement the next stage of our growth strategy, it could put us at the very forefront of the Medical Cannabis Market in Australasia.
7. Should I invest now? What happens if you don’t reach the minimum?
No one will be issued any shares if the minimum isn’t reached which is why it is better for everyone to invest sooner rather than later!
8. When does the campaign finish?
We only have 17 days left before the opportunity closes. All pledges must be made on the PledgeMe platform before 11:59 on June 14. We are not able to issue any extension on top of this.
9. Can I invest from New Zealand?
We can currently only accept investment from relatives and close business associates. Please get in touch with us at [email protected] if this is you.
10. What is the Offer Document?
This is what you should download on our campaign page on PledgeMe. It explains who we are, what we do, what we have done so far, and what we will do in the future.
To invest visit: https://www.pledgeme.com.au/investments/17-cda-health-pty-ltd
We thank you once again for being a part of this journey to increase the access to Medical Cannabis across Australasia for as many patients as possible!
1 week: 50% funded, 101 investors
23/05/2019 at 4:47 PM
1 week, 50% funded, 101 investors
Today marks exactly 1 week since we launched Australia's first Medical Cannabis Equity Crowdfunding campaign.
We want to thank those who have pledged to buy shares so far and remind everyone who is still following along that in order for shares to be successfully issued, we do need to hit our minimum of $500,000.
Of course, this is something we would like to secure sooner rather than later.
Tonight: We’ll answer all investment questions
We've been getting a large number of queries coming through about how the crowdfunding part of the investment works and have spoken to a lot of people who are holding off investing until they learn a bit more.
So, tonight we'll be holding a Facebook Live event with the Founder of the PledgeMe platform, Anna Guenther where we'll be discussing a range of topics including the following:
What is equity crowdfunding?
Who can invest?
How do I invest?
When does my money come out of my account?
What do investors get?
What is a sophisticated investor?
What is my return on investment?
What are the investor benefits?
What are CDA's future plans?
This will run for approximately 45 minutes on the CDA Clinics Facebook Page and will be highly valuable for those who need a bit more clarity on how everything works.
Why this investment is so important…
A lot of patients are in need of Medical Cannabis products as soon as possible and the staggering number of stories from those who have battled with opioid side effects, addiction or negligible results is what makes it critical for us to expand to be able to cater for the 300,000 potential patients.
Benefits CDA will bring to Australia & patients are:
1. Give Australian’s a voice in the trajectory of this new Healthcare industry
2. Give patients immediate access to a specialised doctor to get a prescription
3. Bring product costs down significantly. Below current black market rates.
4. Boost of the Australian economy through local job creation and community investment.
5. Ensuring patients and doctors have safe, reliable access to Medical Cannabis products
6. Increase the number of doctors who feel comfortable prescribing Medical Cannabis
The 2 key outcomes from this investment
- With manufacturing capabilities we will be able to bring costs down by over 40% of the current average prices on the market right now.
- With further doctors we will be able to bring wait times down from 9 weeks to 5 days and be prepared to cater for the expected 15,000 Australian patients by the end of this year.
Your actions can help make these benefits a reality for as little as $250. With that you're able to own a percentage of our company and if CDA Health increases in value, your shares do too.
We’re excited to announce...
Today Vivo Cannabis, a Canadian company listed on the Toronto Stock Exchange, and Burleigh Heads Cannabis signed a distribution agreement to increase the ability of Australian patients to access high-quality Medical Cannabis flower and oils.
This is a testament to the strong CDA supply chain which aims to provide patients with the largest and most affordable product range in Australia, and showcases it's continued ability to provide a market entry solution for international businesses wanting to access Australia's rapidly growing Medical Cannabis market.
Below are the links that can be shared through email and Facebook etc which for every new person that sees it, gives us another potential investor to get us closer to the goal!
We thank you once again for your support and look forward to growing CDA Health together.
You need to pledge to see this update.
You need to pledge to see this update.
|Maximum Shares Offered||2,000,000|
|Dr. Ben Jansen||Chairman & Clinical Director||https://www.linkedin.com/in/dr-ben-jansen-a9126516b||✔|
|Dr. Matua Jansen||Managing Director||https://www.linkedin.com/in/matua-jansen-743782104/||✔|
|Guy Headley||Director of Operations||https://www.linkedin.com/company/cannabis-doctors-australia/||✔|
|Jessimine Jansen||Marketing Director||https://www.linkedin.com/in/jessimine-jansen-62187440/||✔|
Ask a Question (You must login to ask a question)
In the warning statement, it states "Your investment is unlikely to be liquid. This means you are unlikely to be able to sell your shares quickly or at all"
Is this just in the initial set up stage? Will you be able to in years to come, if you wish, cash in and sell your shares??
This is the standard risk warning statement required for all equity crowdfunding campaigns.
You could privately sell your shares however they will not be traded on a secondary market which is why there is low liquidity.
In years to come, there is the potential for an initial public offering on a stock exchange, a merger or sale to another company or a share buyback from the company which are the usual exit events which could allow you to realise the investment.
Thanks for considering investing with us,
The CDA team.
Answered on 17-05-2019 by Cannabis Doctors Australia
Identity verification...As an "other" form of ID, all Utility Bills, Bank or Credit Card statements etc have only my PO Box as my address, not my residential address as I live on a property and have no mail delivered here. Is this a problem?Posted on 16-05-2019 by Kathryn
Does CDA/BHC have any involvement with Cannvalate?Posted on 18-05-2019 by Beau Evans
Are there any investor perks?Posted on 22-05-2019 by phillip mulligan
Hi Phillip, appreciate the question. As much as we would love to give out free samples, we are unfortunately restricted due to the nature of the regulated industry. What we can ensure is that everyone who invests in CDA Health during this campaign will play an integral part of the mission to increase access to Medical Cannabis, bring down product costs and reduce the amount of opioid usage for our patients. This will directly improve the quality of life for thousands of people around Australia. Hopefully this works as an impactful perk!
Answered on 23-05-2019 by Cannabis Doctors Australia
We were wanting to buy shares for our sons 18th.(2 months)
Is this legal to purchase in his name while he’s still 17?
Also, this will be a private investment.
Hi Tracey, unfortunately, we can't sell shares directly to minors, however, we can sell to you as parent as a trustee (held in your name with the beneficial interest held by your son). Once he turns 18 you can then transfer them into his name.
You could buy the shares in your name and transfer them over to him when he turns 18, however, in this scenario there is a chance they will incur capital gains to be paid if the shares increase in value before the transfer is done.
Hope that answers your question - we would love to have you onboard!
Answered on 29-05-2019 by Cannabis Doctors Australia
Hello I’m very excited where medical marijuana is heading and would love to be apart of your company independently leading the way ! So if I buy shares as an investment so in 10 or more years I can sell for my retirement fund is this possible through pledge me investing ??Posted on 08-06-2019 by Sandra Cowcher Black
Hi Sandra, that is great to hear and thanks for your support! We're aiming to provide an opportunity for you to sell your shares either privately, on a stock exchange, through a merger or sale to another company or a share buyback from the company. 10 or more years should be enough time for us to accomplish this but we can not make any guarantees at this stage.
It is also possible for us to issue shares to a Self Managed Super Fund directly. To do this just register and make a pledge as an individual on the PledgeMe site and then email [email protected] letting them know you would like the shares in the name of the SMSF, they will advise what information is needed to finalise this. Thanks again!
Answered on 10-06-2019 by Cannabis Doctors Australia
How do I pay through bank transfer?Posted on 11-06-2019 by Michael Beno
Hi Michael, once the campaign closes and PledgeMe have verified your identity you will receive bank details to complete the transfer. This will be via email and a notification on your profile. Thanks!
Answered on 12-06-2019 by Cannabis Doctors Australia
Hey guys, super stoked to be on board with CDA in this exciting chapter. Question about dividends - should there be any, will they be paid annually or bi-annually the same way as other shares are? Thanks!Posted on 12-06-2019 by Cassidy Curran
Hi cassidy, thanks so much for your support!
Early stage companies rarely pay dividends as they often reinvest profits (if any) into growing the company for the shareholders benefit. Even a large number of listed companies do not pay dividends to shareholders, instead opting to reinvest profits back into the company to generate growth in its value.
In these cases, investors could make money by selling their shares for a capital gain (the value of the company increasing between the purchase and sale of shares). The mechanism for selling those shares could be by the company listing, through a trade sale, or if a willing buyer is found for those shares.
We are planning to reinvest profits to grow the company and create an exit opportunity for our investors. There is a possibility for CDA to declare a dividend in the future but we do not have any intentions to do so in the short term.
Answered on 12-06-2019 by Cannabis Doctors Australia
Followers of CDA Health Pty Ltd
2019-06-14 18:43:44 +1000
2019-06-14 18:39:26 +1000
2019-06-14 18:38:02 +1000
2019-06-14 18:36:24 +1000
2019-06-14 18:36:09 +1000
2019-06-14 18:32:40 +1000
2019-06-14 18:25:43 +1000
"I know its only a small amount but I hope it helps. Kind regards Laura Marcinkowsky "
2019-06-14 18:25:21 +1000
"Maia Kahukura ... Whakaki "
2019-06-14 18:24:34 +1000
2019-06-14 18:18:05 +1000
2019-06-14 18:15:41 +1000
2019-06-14 18:13:56 +1000
2019-06-14 18:13:55 +1000
2019-06-14 18:13:25 +1000
2019-06-14 18:06:17 +1000
2019-06-14 18:04:32 +1000
2019-06-14 18:01:31 +1000
2019-06-14 17:55:16 +1000
2019-06-14 17:46:42 +1000
2019-06-14 17:46:41 +1000
2019-06-14 17:43:36 +1000
2019-06-14 17:42:11 +1000
2019-06-14 17:41:48 +1000
2019-06-14 17:31:53 +1000
2019-06-14 17:30:59 +1000
2019-06-14 17:29:34 +1000
2019-06-14 17:28:11 +1000
2019-06-14 17:23:58 +1000
2019-06-14 17:20:32 +1000
2019-06-14 17:06:31 +1000
"Referred by its not Kate's time. "
This campaign has closed, but this company may choose to do more equity raises on PledgeMe in the future. If you're interested in investing in CDA Health Pty Ltd, you can sign up to be notified when a new equity campaign from this company is published.
General Public (Retail Investors)
We can accept investments from retail investors up to a maximum of AU$10,000.
We can only accept investment amounts over AU$10,000 if you can provide a "Sophisticated Investor certificate" in compliance with Chapter 6D of the Australian Corporations Act.